Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations
Clinical trial NCT03454919 · UNKNOWN
Trial details
- NCT number
- NCT03454919
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-30
- Primary completion
- 2019-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.